<div id="readability-page-1">Fosun Health Group, a subsidiary of Fosun Pharmaceutical, said it plans to build its first overseas hospitals in Indonesia amid a push by Chinese healthcare companies to expand abroad. The announcement underscores Indonesia’s appeal – home to the world’s fourth-largest population of 287 million – as Beijing encourages its healthcare sector to “go global”. Fosun Health planned to establish “several hospitals” in Indonesia, CEO Frank Hu Hang told delegates at the South China Morning Post’s China Conference: Southeast Asia 2026, in Jakarta on Tuesday. “We’ve signed term sheets with local partners, but not yet formally signed any contracts,” Hu told the SCMP. He did not disclose how many hospitals would be built or where they would be located. Fosun was also exploring opportunities to work with local distributors to sell its products in Indonesia, as well as expanding cooperation with local manufacturers, he said. Established in 2010, Shanghai-based Fosun Health Group operated 19 hospitals, clinics and third-party diagnostics centres in mainland China as of June 2025.  The company has accelerated its global expansion in recent years, including engaging in preliminary talks to launch medical services in Bangladesh and Mongolia. Fosun is one of several Chinese healthcare firms looking abroad for growth, particularly in regions such as the Middle East and Southeast Asia where there are significant Chinese communities and demand for medical services is not being met by local firms. Hu told the SCMP last October that Fosun was targeting markets in South Asia, Southeast Asia and the Middle East due to their economic growth and fragmented health systems. Indonesia, in particular, had a shortage of health professionals, he said, with just 0.6 doctors for every 1,000 people. During a panel discussion on Tuesday about the role of Indonesia in shoring up international supply chains, Hu said Fosun’s experience in providing internet-based medical services in China could benefit customers in Indonesia. He urged the Indonesian government to accelerate the digitisation of supply chains, using China as a template, and called for continuity in government policy to incentivise more Chinese companies to invest. “I think there will be more opportunities between our group and our partners in the Indonesia market,” he said.</div>

<p>Fosun Health Group plans to build its first overseas hospitals in Indonesia, aiming to expand amid China's push for global healthcare growth. CEO Frank Hu announced the initiative at a conference, highlighting Indonesia's large population and healthcare needs. While term sheets with local partners have been signed, formal contracts are pending. Fosun is also exploring local product distribution and manufacturing partnerships. The company, which operates 19 facilities in China, is targeting markets in South Asia, Southeast Asia, and the Middle East due to their economic growth and healthcare demands.</p>

南华早报

Dacheng CSI All Share Health Care Equipment and Services ETF

ChinaAMC SSE Health Care ETF Initiating Fund

E Fund Hang Seng SCHK Innovative Drug ETF

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

Maxwealth CSI All Share Medical Apparatus and Instruments ETF

Bosera Hang Seng SCHK Innovative Drug Select ETF

FOSUN PHARMA

Guotai CSI Bio-medicine ETF

Bosera Hang Seng Health Care ETF(QDII)

Penghua CSI HK Connect Health Care Composite ETF

ChinaAMC CSI All Share Health Care Devices ETF

E Fund CSI 300 Health Care ETF

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

China Merchants CSI All Share Medical Apparatus and Instruments ETF

Fosun Health to build first overseas hospitals in Indonesia amid global push